Company Filing History:
1 out of 855 
1 out of 1 Years Active: 2023
Title: Minako Aihara: Innovator in NKT Cell Activation Technology
Introduction
Minako Aihara is a prominent inventor based in Wako, Japan. She has made significant contributions to the field of immunology, particularly in the activation of NKT cells. Her innovative work has led to advancements in methods that enhance the proliferation and activity of these important immune cells.
Latest Patents
Minako Aihara holds a patent for a technology that focuses on the efficient activation of NKT cells. The patent describes a method for producing an NKT cell ligand-pulsed human CD14 positive cell that activates NKT cells and induces their proliferation, IFN-γ production, and cytotoxic activity. The method involves culturing isolated CD14 positive cells in a medium containing an NKT cell ligand and GM-CSF, while being substantially free of IL-4. Additionally, the invention includes a method for producing an NKT cell ligand-pulsed human CD14 positive cell line, characterized by culturing isolated CD14 positive cells in a medium containing an NKT cell ligand and being free of GM-CSF and IL-4. Furthermore, the invention encompasses a cell preparation containing an NKT cell ligand-pulsed human CD14 positive cell or cell line, along with its pharmaceutical applications.
Career Highlights
Throughout her career, Minako Aihara has worked with notable organizations, including Riken Corporation and Ambicion Co., Ltd. Her experience in these companies has allowed her to develop her expertise in immunological research and innovation.
Collaborations
Minako has collaborated with esteemed colleagues such as Masaru Taniguchi and Tomokuni Shigeura. These partnerships have contributed to her research and the advancement of her patented technologies.
Conclusion
Minako Aihara is a trailblazer in the field of NKT cell activation technology, with her innovative methods paving the way for future advancements in immunotherapy. Her contributions are vital to the ongoing research and development in this important area of medicine.